Swiss pharmaceutical giant Novartis, a current and former subsidiary, has agreed to pay a total of $346.7m to reach settlements with the US Department of Justice (DOJ) and Securities and Exchange Commission (SEC) following investigations into bribery schemes.
The DOJ …
Read More
Senator presses SEC’s Clayton over “Main St” letters report
A US Senator has called on the head of the US financial regulator to provide an update on the status of its reports into “apparently fraudulent comment letters” that showed support for proposed new rules on proxy advice.
In a …
Read More